COMPOSITION FOR THE TREATMENT OF NASOPHARYNGEAL CARCINOMA AND METHOD OF USE THEREOF

Disclosed is a novel drug combination which is useful for the treatment of nasopharyngeal carcinoma, said novel drug combination comprising one or more of a farnesyl transferase inhibitor and one or more of an anthracyline. L'invention concerne une nouvelle combinaison de médicaments utilisée p...

Full description

Saved in:
Bibliographic Details
Main Authors PREVOST, GREGOIRE, BUSSON, PIERRE, VICAT, JEAN-MICHEL
Format Patent
LanguageEnglish
French
Published 08.04.2004
Edition7
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:Disclosed is a novel drug combination which is useful for the treatment of nasopharyngeal carcinoma, said novel drug combination comprising one or more of a farnesyl transferase inhibitor and one or more of an anthracyline. L'invention concerne une nouvelle combinaison de médicaments utilisée pour traiter le cancer du nasopharynx. Cette nouvelle combinaison de médicaments comprend un ou plusieurs inhibiteurs de farnésyl transférase et une ou plusieurs anthracylines.
Bibliography:Application Number: WO2003IB04922